Jackson Square Capital, LLC Abb Vie Inc. Transaction History

Jackson Square Capital, LLC

$381 Million
Q3 2024

A detailed history of Jackson Square Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Jackson Square Capital, LLC holds 25,786 shares of ABBV stock, worth $4.37 Million. This represents 1.34% of its overall portfolio holdings.

Number of Shares

25,786

Previous 25,231 2.2%

Holding current value

$4.37 Million

Previous $4.33 Million 17.68%

% of portfolio

1.34%

Previous 1.12%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$163.84 - $199.33 $90,931 - $110,628	555 Added 2.2%	25,786 $5.09 Million
Q2 2024 Aug 05, 2024	SELL	$154.79 - $180.76 $3.35 Million - $3.92 Million	-21,672 Reduced 46.21%	25,231 $4.33 Million
Q1 2024 Apr 16, 2024	BUY	$159.82 - $182.1 $38,516 - $43,886	241 Added 0.52%	46,903 $8.54 Million
Q4 2023 Jan 09, 2024	SELL	$137.6 - $154.97 $153,561 - $172,946	-1,116 Reduced 2.34%	46,662 $7.23 Million
Q3 2023 Oct 25, 2023	BUY	$133.59 - $154.65 $265,176 - $306,980	1,985 Added 4.33%	47,778 $7.12 Million
Q2 2023 Jul 28, 2023	SELL	$132.51 - $164.9 $1.41 Million - $1.76 Million	-10,671 Reduced 18.9%	45,793 $6.17 Million
Q1 2023 Apr 21, 2023	BUY	$144.61 - $166.54 $2.03 Million - $2.34 Million	14,036 Added 33.08%	56,464 $9 Million
Q4 2022 Jan 23, 2023	BUY	$138.31 - $165.87 $33,747 - $40,472	244 Added 0.58%	42,428 $0
Q3 2022 Oct 13, 2022	BUY	$134.21 - $153.93 $337,672 - $387,287	2,516 Added 6.34%	42,184 $5.66 Million
Q2 2022 Jul 25, 2022	BUY	$137.62 - $174.96 $1.45 Million - $1.85 Million	10,558 Added 36.27%	39,668 $6.08 Million
Q1 2022 Apr 20, 2022	BUY	$131.98 - $163.75 $689,859 - $855,921	5,227 Added 21.89%	29,110 $4.72 Million
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $387,607 - $490,435	3,608 Added 17.8%	23,883 $3.23 Million
Q3 2021 Oct 21, 2021	BUY	$106.4 - $120.78 $395,063 - $448,456	3,713 Added 22.42%	20,275 $2.19 Million
Q2 2021 Jul 20, 2021	BUY	$105.21 - $117.21 $182,854 - $203,710	1,738 Added 11.72%	16,562 $1.87 Million
Q1 2021 May 18, 2021	BUY	$102.3 - $112.62 $178,002 - $195,958	1,740 Added 13.3%	14,824 $1.6 Million
Q4 2020 Mar 05, 2021	SELL	$80.49 - $108.67 $844,823 - $1.14 Million	-10,496 Reduced 44.51%	13,084 $1.4 Million
Q3 2020 Nov 17, 2020	BUY	$85.91 - $100.83 $32,130 - $37,710	374 Added 1.61%	23,580 $2.07 Million
Q2 2020 Aug 18, 2020	BUY	$73.37 - $98.18 $1.66 Million - $2.22 Million	22,652 Added 4088.81%	23,206 $2.28 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $29,928 - $45,374	464 Added 515.56%	554 $42,000
Q4 2019 May 15, 2020	BUY	$72.13 - $90.25 $6,491 - $8,122	90 New	90 $8,000

Others Institutions Holding ABBV

# of Institutions

3,837

Shares Held

1.25B

Call Options Held

15.7M

Put Options Held

11.3M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $300B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Square Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Square Capital, LLC with notifications on news.

Account

Jackson Square Capital, LLC Abb Vie Inc. Transaction History